LOXL1 Polymorphism in Pseudoexfoliation Syndrome
NCT01515735 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2012-01-24
Summary
To evaluate the association profiles of the lysyl oxidase-like 1 gene polymorphisms with pseudoexfoliation syndrome in the Korean population, Genotypes of lysyl oxidase-like 1 gene were analyzed by direct sequencing.
Conditions
- Pseudoexfoliation Syndrome
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Principal Investigators
-
Changwon Kee, M.D., PhD · Samsung Medical Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Clinical Variability in Marfan Syndrome
NCT01707563 ·Status: COMPLETED ·Phase: NA
-
Study of in Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis
NCT05312073 ·Status: COMPLETED ·Phase: NA
-
Elastography Ultrasound in Localized Scleroderma (Morphea) Study
NCT06847750 ·Status: ENROLLING_BY_INVITATION
-
TL1A Expression in Psoriatic Skin
NCT01744327 ·Status: UNKNOWN
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
NCT02810951 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers
NCT01971957 ·Status: COMPLETED
-
Alteration of Dermal Elastic Fibers During Calcifying Dermatosis: Structural Study Using Multiphoton Microscopy
NCT05112744 ·Status: UNKNOWN
-
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15
NCT03893643 ·Status: UNKNOWN
-
A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
NCT05979831 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Pathology of Helicases and Premature Aging: Study by Derivation of hiPS
NCT03898817 ·Status: TERMINATED
-
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
NCT06177353 ·Status: RECRUITING
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA
-
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diagnostic Role of Renal Biopsy in Patients With Fabry Disease
NCT06801288 ·Status: COMPLETED
-
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
NCT03957681 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa
NCT04285294 ·Status: UNKNOWN
-
Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
NCT00716014 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
NCT01044043 ·Status: COMPLETED
-
Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls
NCT00213525 ·Status: COMPLETED
-
Simvastatin Treatment of Pachyonychia Congenita
NCT01382511 ·Status: UNKNOWN ·Phase: NA
-
Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
NCT00555633 ·Status: COMPLETED
-
Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis
NCT01268202 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Signatures in Inflammatory Skin Disease
NCT03358693 ·Status: RECRUITING
-
Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
NCT06857240 ·Status: RECRUITING ·Phase: PHASE2